Navigation Links
NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
Date:2/12/2008

174 centers and 1,022 patients at the end of the fourth quarter of 2006 and 306 centers and 1,957 patients at the end of the third quarter of 2007. NxStage also continued to expand use of the PureFlow SL(TM) to a broader customer base and at the end of the fourth quarter 2007, PureFlow penetration reached 70% of all System One machines in the chronic home dialysis market. Expanding penetration of PureFlow among existing and new customers is an important element of NxStage's ongoing focus to improve margins.

NxStage reported a net loss of $17.4 million, or ($0.47) per share, for the fourth quarter of 2007 compared with a net loss of $10.4 million, or ($0.37) per share, for the fourth quarter of 2006 and $16.1 million, or ($0.54) per share for the third quarter of 2007, reflecting improved gross margins offset by increased spending in sales and marketing in support of the ongoing launch of the System One and increased distribution expenses in the chronic home hemodialysis market. Fourth quarter 2007 net loss includes $3.2 million in charges primarily related to the acquisition of Medisystems that are not expected to recur.

For the full year 2007, the Company's net loss was $58.4 million, or ($1.86) per share, compared to a net loss of $39.6 million, or ($1.60) per share, in 2006, reflecting improved gross margins offset by increased spending in operating expenses as the Company continues to build its infrastructure to support the business.

Cash, cash equivalents and short term investments as of December 31, 2007 were $34.3 million, compared to $61.8 million at the end of 2006.

"2007 was a transformational year for NxStage. We completed a major, strategic acquisition that dramatically increased the Company's scale and capabilities. We are now in three dialysis markets: home, critical care and in-center," said Jeffrey H. Burbank, President & CEO of NxStage Medical. "In our existing business, we formed key supply and distribution agreements a
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
2. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
3. NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
4. NxStage Medical Reports Third Quarter 2007 Results
5. NxStage Medical Completes Acquisition of Medisystems
6. Aircraft Medical Files Counter Action Against Verathon
7. NHS Choices Launches Medical News Guide to What Lies Behind the Headlines
8. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
9. Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 1
10. Harnessing Human Energy for Medical Good
11. Pennsylvania Corrections Department to Extend Medical Contract, Save $55 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...estering drug tetrathiomolybdate (TM) has been sho...Wilson disease, a disease caused by an overload of... is known. Very little, however, is known about ho... study led by Northwestern University researchers ...ensional structure of TM bound to copper-loaded me...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a le...ina, today announced the expansion of its services...ist, Dr. Doug Macmillan. , ...l is pleased to announce that Dr. Doug Macmillan, ...eted an additional advanced training seminar. RTD...
(Date:11/25/2009)...E,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharm...ecompanywillhosttwoinvestoreventsinDecember: ,,.../10:00a.m.ET ,, Principalinvestigatorswilldis...sedand/orrefractorymultiplemyeloma,asfeaturedatthe...ndExpositioninNewOrleans,LA.Theteleconferencewillb...
(Date:11/25/2009)...S,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInsti...eexecutiveleadershipfor2010. ,, ThenewBoardMemb...npublicpolicy,law,finance,governmenthealthprograms...ocomesfromawiderangeofpersonalbackgroundsincluding...ithHIVthemselves,andrepresentingmultipleagegroups....
(Date:11/25/2009)...discovery that grew out of a collaboration between...ffer hope to the nearly 10 million Americans who s...so known as hardening of the arteries, peripheral ...problem in which narrowed arteries reduce blood fl... flag for vascular disease, heart attack and strok...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
...illoma virus (HPV), is the virus that causes cervi...f the uterus, known as cervix. It is transmitted s...launched Gardasil and GlaxoSmithKline Plc's has in...omed in rich countries but it is very doubtful how...
...rs have shown that oral contraceptives taken on a ... safe to use.They claim that it is both safe and e... Contraception”. There are low dose OCP’s in the ...enstrual periods altogether. "It is felt that...
...ational group of researchers has discovered that t...amilial pancreatic cancer. The findings may help e...h project was led by Dr. Teri Brentnall, Universit...eatic cancer is usually a fatal diagnosis. One of ...
...nd more Americans turn to in-home health care work...ch from a University of Iowa law professor has fou... Peggie Smith, an expert in employment law, has f... part, those government agencies responsible for e...
...nter study on treating common ear infections in ch...idence that favors antibiotic ear drops over antib...cases, a UT Southwestern Medical Center researcher...s in children with ear tubes than merely taking or...
...ves would be fortified with certain vitamins, in o..., Government-commissioned report expected// supple... bread would prevent neural tube effects like spin...a and nervous problems in the long run. The p...
Other Medicine News:Health News:Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations 2Health News:Team Discovers a Gene That Causes Familial Pancreatic Cancer 2Health News:Team Discovers a Gene That Causes Familial Pancreatic Cancer 3Health News:Law Professor Finds Home Health Care Workers Have Few Legal Protections 2Health News:Law Professor Finds Home Health Care Workers Have Few Legal Protections 3Health News:Antibiotic Ear Drops Favored Over Oral Antibiotics for Ear Infections 2Health News:Folic Acid Supplementation in Bread: Boon to Neonates and Curse to Pensioners 2
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomH...sfollowinganautoaccident,wasactuallyfullyconscious...ngAmericasegment.TheDynaVoxEyeMaxwasfeaturedinthes...dotherconditionscanunlockcommunication. ,, WHEN...onlineat www.dynavoxtech.com ,, WHO:RomH...
(Date:11/24/2009)..., MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--Ques...dingproviderofdiagnostictesting,informationandserv...ualPiperJaffrayHealthcareConferenceinNewYorkCity.T...09at9:30a.m.EasternTime. ,, Duringtheconference...owthtoapproximate3%,operatingincometoexceed18%ofre...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--AnadysPh...titwillpresentatthe21stAnnualPiperJaffrayHealthcar...:00a.m.PST).TheconferenceisbeingheldatTheNewYorkPa...utiveOfficerofAnadys,willprovideanoverviewofAnadys... ,, Thecorporatepresentationwillbesimultaneousl...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 1Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 5Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown Declares Frost 26amp 3B Sullivan 5581 1Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown Declares Frost 26amp 3B Sullivan 5581 2Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown Declares Frost 26amp 3B Sullivan 5581 3The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 1The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 3
...N, Germany, June 21, 2007 /PRNewswire/ --,Pieris A...ins(R), a,novel class of targeted human protein th...uocalin(R) technology has successfully,demonstrate...evelopment, Dr Andreas Hohlbaum, Director of,Scien... Pieris,continues to validate the therapeutic appl...
... Demonstrates the Promise of Anacor,s,Boron-Based ...Calif., June 21, 2007 /PRNewswire/ -- Anacor,Pharm...y, announced,today that the journal Science will p..., the company,s lead clinical candidate,kills fun...fic,protein required for fungal growth. This uniqu...
Other Medicine Technology:Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 2Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 3Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 2Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 3
...gital camera incorporates a Progressive Scan 1/2" ...ivity (1280 (H) x 960 (V) SXGA. Whats more the XCD...lled a "Bayer filter") and outputs the "raw color"...color image on the computer. The color conversion ...
... most popular machine vision camera. It is a monoc...lobal shutter, external trigger and a rich set of ...al video streams to the computer. The PL-A741 com...CMOS imager to provide a solid machine vision came...
... most popular microscopy camera. The PL-A662 is a ... use in brightfield microscopy. The PL-A662 is Pi...o simplify real-time uncompressed video display an...uncompromising video and digital still-image quali...
...APTURE digital camera photomicrographic system can...uch as Olympus, Leica, Nikon, and Zeiss, making bu...over the Internet easy and fast. Featuring a 4.14-...ikkor lens. The system records photomicrographic i...
Medicine Products: